Hydroxycarbamide (INN, BAN) or hydroxyurea (USAN, AAN) is an antineoplastic
drug used in myeloproliferative disorders, specifically polycythemia vera and ...
Oct 15, 2015 ... Hydroxyurea can cause a severe decrease in the number of blood cells in your
bone marrow. This may cause certain symptoms and may ...
Easy to read patient leaflet for hydroxyurea. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Hydroxyurea capsules, USP is indicated to reduce the frequency of painful crises
and to reduce the need for blood transfusions in patients with sickle cell ...
Jun 9, 2015 ... Consumer information about the prescription drug hydroxyurea (Hydrea, Droxia).
Hydroxyurea is used to treat some forms of leukemia, cancers ...
Medscape - Indication-specific dosing for Droxia, Hydrea (hydroxyurea),
frequency-based adverse effects, comprehensive interactions, contraindications,
Hydroxyurea is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug
. Hydroxyurea is classified as an "antimetabolite." (For more detail, see "How ...
Nov 19, 2015 ... Hydroxyurea is a prescription drug sold under the brand name Hydrea. It's used
to treat psoriasis, chronic myelogenous leukemia (a cancer of ...
Name, Hydroxyurea. Accession Number, DB01005 (APRD00023). Type, Small
Molecule. Groups, Approved. Description. An antineoplastic agent that inhibits ...
Apr 22, 1998 ... Use of Hydroxyurea in Patients with Sickle Cell Disease. The Multicenter Study of
Hydroxyurea in Sickle Cell Anemia (MSH). The MSH study ...